Peter Soparkar - Net Worth and Insider Trading
Peter Soparkar Net Worth
The estimated net worth of Peter Soparkar is at least $212,712 dollars as of 2024-05-30. Peter Soparkar is the COO of Adverum Biotechnologies Inc and owns about 26,589 shares of Adverum Biotechnologies Inc (ADVM) stock worth over $212,712. Details can be seen in Peter Soparkar's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Peter Soparkar has not made any transactions after 2023-03-15 and currently still holds the listed stock(s).
Transaction Summary of Peter Soparkar
Peter Soparkar Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter Soparkar owns 1 companies in total, including Adverum Biotechnologies Inc (ADVM) .
Click here to see the complete history of Peter Soparkar’s form 4 insider trades.
Insider Ownership Summary of Peter Soparkar
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADVM | Adverum Biotechnologies Inc | 2023-03-15 | Chief Legal Officer |
Peter Soparkar Latest Holdings Summary
Peter Soparkar currently owns a total of 1 stock. Peter Soparkar owns 26,589 shares of Adverum Biotechnologies Inc (ADVM) as of March 15, 2023, with a value of $212,712.
Latest Holdings of Peter Soparkar
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ADVM | Adverum Biotechnologies Inc | 2023-03-15 | 26,589 | 8.00 | 212,712 |
Holding Weightings of Peter Soparkar
Peter Soparkar Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter Soparkar has made a total of 5 transactions in Adverum Biotechnologies Inc (ADVM) over the past 5 years, including 3 buys and 2 sells. The most-recent trade in Adverum Biotechnologies Inc is the sale of 1,336 shares on March 15, 2023, which brought Peter Soparkar around $10,421.
Insider Trading History of Peter Soparkar
- 1
Peter Soparkar Trading Performance
GuruFocus tracks the stock performance after each of Peter Soparkar's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter Soparkar is 3.45%. GuruFocus also compares Peter Soparkar's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter Soparkar within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Peter Soparkar's insider trading performs compared to the benchmark.
Performance of Peter Soparkar
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -13.41 | | | | | |
| Relative Return to S&P 500(%) | -8.8 | | | | | |
Peter Soparkar Ownership Network
Peter Soparkar Owned Company Details
What does Adverum Biotechnologies Inc do?
Who are the key executives at Adverum Biotechnologies Inc?
Peter Soparkar is the Chief Legal Officer of Adverum Biotechnologies Inc. Other key executives at Adverum Biotechnologies Inc include Chief Development Officer Setareh Seyedkazemi , Chief Financial Officer Linda M Rubinstein , and Chief Scientific Officer Brigit Riley .
Adverum Biotechnologies Inc (ADVM) Insider Trades Summary
Over the past 18 months, Peter Soparkar made 1 insider transaction in Adverum Biotechnologies Inc (ADVM) with a net sale of 13,360. Other recent insider transactions involving Adverum Biotechnologies Inc (ADVM) include a net purchase of 130,000 shares made by Lupher, Jr. Mark L. , a net purchase of 100,000 shares made by Linda M Rubinstein , and a net purchase of 100,000 shares made by James Paul Scopa .
In summary, during the past 3 months, insiders sold 0 shares of Adverum Biotechnologies Inc (ADVM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,810 shares of Adverum Biotechnologies Inc (ADVM) were sold and 33,000 shares were bought by its insiders, resulting in a net purchase of 26,190 shares.
Adverum Biotechnologies Inc (ADVM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adverum Biotechnologies Inc Insider Transactions
Peter Soparkar Mailing Address
Above is the net worth, insider trading, and ownership report for Peter Soparkar. You might contact Peter Soparkar via mailing address: C/o Adverum Biotechnologies, Inc., 100 Cardinal Way, Redwood City Ca 94063.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
